超声治疗仪联合血脂康降低血脂的临床疗效观察

目的：观察超声治疗仪联合血脂康在降低血脂中的应用效果。方法：选择在黑龙江省医院中西医结合科治疗的高脂血症患者80例,随机将其分为采用超声治疗仪联合血脂康治疗的观察组和仅单独采用血脂康降脂治疗的对照组,每组40例,比较两组患者的总体治疗效果和治疗前后血液中的血脂水平。结果：两组患者治疗的总有效率比较差异具有统计学意义（x2=13.536,P〈0.05）;观察组治疗前后组内比较血甘油三酯（TG）、总胆固醇（TC）、高密度脂蛋白（HDL-C）和低密度脂蛋白（LDL-C）,差异均具有统计学意义（t=3.265,t=4.021,t=-2.871,t=3.665;P〈0.05）。对照组在治疗前后组内比较TG、TC和LDL-C差异均具有统计学意义（t=2.18,t=2.994,t=2.276;P〈0.05）。治疗后两组组间比较TG、TC、HDL-C和LDL-C差异均具有统计学意义（t=-2.998,t=-3.046,t=2.887,t=3.028;P〈0.05）。结论：采用超声治疗仪联合血脂康进行降脂治疗,能够显著降低患者的血脂水平,并且疗效显著,值得临床推广应用。

The clinical efficacy in lowering blood lipids with ultrasound therapy device and Xuezhikang

Objective： To observe the clinical efficacy in lowering blood lipids with ultrasound therapy device and Xuezhikang. Methods：Selected 80 cases as an object of study in Heilongjiang Provincial Hospital Integrative Medicine treated from January 2013 to July 2014, the observation group 40 cases, used ultrasound therapy device and Xuezhikang, control group 40 cases, only single use of Xuezhikang overall treatment, compared the two groups of patients before and after treatment and lipid levels in the blood. Results：The total efficiency of compared two groups of patients, a statistically significant （x2=13.536, P〈0.05）;compare TG group before and after treatment in the observation group, TC, HDL-C, LDL-C, were statistically significant（t=3.265, t=4.021, t=-2.871, t=3.665;P〈0.05）. In the control group before and after treatment group TG, TC, LDL-C were statistically significant （t=2.18, t=2.994, t=2.276;P〈0.05）. After treatment, the comparison between the two groups TG, TC, HDL-C, LDL-C, were statistically significant （t=-2.998, t=-3.046, t=2.887, t=3.028;P〈0.05）. Conclusion：Combined use of ultrasound therapy device and Xuezhikang lipid-lowering therapy, can significantly lower blood lipid levels in patients, and the effect is significant, worthy of clinical application.